Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Healthequity (NQ: HQY )

104.65 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Healthequity

< Previous 1 2 3 4 5 6 7 Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
Cboe's Weekly Market Recap: May 30th To June 3rd
Attention shifted from the markets to those who lost their lives in service to the U.S. on Memorial Day. 
Via Benzinga
6 Analysts Have This to Say About HealthEquity
Within the last quarter, HealthEquity (NASDAQ:HQY) has observed the following analyst ratings: 
Via Benzinga
HealthEquity Gains After Q1 Results, Guides FY23 Revenue Above Consensus
Via Benzinga
Recap: HealthEquity Q4 Earnings
HealthEquity (NASDAQ:HQY) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
CNBC's Final Trades: Marathon Petroleum, HealthEquity, Cash And This Fast Food Major
On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners said that Marathon Petroleum Corp (NYSE: MPC) is “the way to 
Via Benzinga
7 Stocks Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Earnings Scheduled For June 6, 2022
Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is projected to report quarterly loss at $0.06 per share on revenue of $39.46 million. 
Via Benzinga
5 Stocks To Watch For June 6, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
HealthEquity's Earnings: A Preview
HealthEquity (NASDAQ:HQY) is set to give its latest quarterly earnings report on Monday, 2022-06-06. Here's what investors need to know before the announcement. Analysts estimate that HealthEquity will... 
Via Benzinga
Analyst Ratings For HealthEquity
Within the last quarter, HealthEquity (NASDAQ:HQY) has observed the followin... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
Upgrades 
Via Benzinga
Where HealthEquity Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on HealthEquity (NASDAQ:HQY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
Upgrades 
Via Benzinga
Futures Slide As VIX Jumps And Oil Rally Accelerates; Bond Rout Fizzles
Contracts on the Nasdaq 100 were down 0.5% at 7:15 am in New York, while S&P 500 and Dow futures fell 0.4%. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
Upgrades 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings, Fed Speakers
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped around 250 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Earnings Scheduled For March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... 
Via Benzinga
Earnings Outlook For HealthEquity
HealthEquity (NASDAQ:HQY) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
CNBC's Final Trades: HealthEquity, Carlyle, Cameco, Citigroup And This Retailer
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said HealthEquity Inc’s (NASDAQ: HQY) stock had “a terrible year” in 2021. 
Via Benzinga
All The Stocks That Moved From CNBC's 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market moving news to investors. The commentary delivered by hosts of the show often move the stocks mentioned.... 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 500 Points; AeroVironment Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 1.47% to 35,743.21 while the NASDAQ rose 3.10% to 15,697.72. The S&P also rose, gaining 2.11% to 4,688.75. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Nasdaq Rises 3%; MongoDB Shares Surge Following Strong Q3 Results
Midway through trading Tuesday, the Dow traded up 1.55% to 35,771.42 while the NASDAQ rose 3% to 15,681.69. The S&P also rose, gaining 2.14% to 4,690.04. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
54 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and... 
Via Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 123.2% to $6.16. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; AutoZone Tops Q1 Views
Following the market opening Tuesday, the Dow traded up 1.52% to 35,761.30 while the NASDAQ rose 2.84% to 15,656.94. The S&P also rose, gaining 2.04% to 4,685.39. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
Upgrades For CarMax Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.